Yosuke Shimizu
Papers
2
Total Citations
14
H-Index
2
About
Yosuke Shimizu is a surgical outcomes researcher whose work focuses on optimizing perioperative management in robot-assisted radical prostatectomy. His key research areas include the impact of antiplatelet therapy and aging on surgical complications. In his 2024 study on thienopyridine-class antiplatelets (ticlopidine, clopidogrel, and prasugrel), Shimizu demonstrated that these agents significantly increase bleeding risks following robot-assisted radical prostatectomy, providing critical guidance for preoperative medication management. His parallel investigation into aging effects revealed that elderly patients face elevated complication rates, informing risk stratification protocols. Both papers have garnered 7 citations each within their first year, reflecting their immediate clinical relevance. Shimizu’s work is notable for leveraging large-scale database analyses to generate evidence-based recommendations for urological surgeons. His contributions are particularly valuable given the growing adoption of robotic surgery and the increasing prevalence of elderly patients and those on antiplatelet therapy. By clarifying the trade-offs between thrombotic protection and hemorrhagic risk, Shimizu helps clinicians make safer decisions in high-stakes surgical settings.
Research Focus
Key Achievements
Top Papers
- 1
- 2